Christie Ballantyne, MD, says high extension enrollment and a single 20-mg daily dose are encouraging signs for patient adherence to oral enlicitide.
|Articles|March 30, 2022
- March 2022
- Volume 88
- Issue 3
Pet Peeves: March 2022
Brought to you by the Sassy Pharmacist
Advertisement
ASAP With an Attitude
When pharmacists ask patients when they would like to pick up their prescriptions, and they say, “now” or “as soon as it is ready.”
No Can Do
When a patient comes to the pharmacy to refund a front-end item.
Early Arrival
When patients show up at the pharmacy before it opens, expecting their prescriptions to have been filled overnight.
What’s Bothering You?
Bossy patients, abandoned prescriptions, drive-through demands? We want to know! Send your pet peeves to cmollison@pharmacytimes.com. We’ll share them here and online.
Articles in this issue
over 4 years ago
Case Studies: March 2022over 4 years ago
OTC Product News: March 2022over 4 years ago
Vuity From Allerganover 4 years ago
Skinny Labeling Allows More Drugs to Enter the Marketover 4 years ago
Flexible Practice Models Can Expand Patient Care Servicesover 4 years ago
March 2022 Rx Product Newsover 4 years ago
Pharmacist Imposter Flees PremisesAdvertisement
Related to this article
An ASRA-recognized quality improvement project draws attention to injectate reproducibility, offering a starting point for examining medication preparation and pharmacists’ role in safer pain procedures.
A meta-analysis presented at IDWeek 2026 found responses were stronger after chemotherapy but waned within a year, supporting a 2-dose strategy.
How should a factor XIa inhibitor be incorporated into secondary stroke prevention?
Inconsistent state immunization laws complicate pharmacy operations and limit patient access.
Pharmacists can strengthen opioid safety through individualized counseling, overdose prevention, and coordinated follow-up that keeps patients involved in treatment decisions.
OCEANIC-STROKE supports a potential additional antithrombotic approach for select patients after noncardioembolic stroke or high-risk TIA.
Nicole Albanese, PharmD, explains how a structured testing schedule and simple notes help patients bring useful glucose data to their care team.
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Reportedly Shelves Commissioner's National Priority Voucher Program
2
Belantamab Mafodotin Moves Into Lenalidomide-Refractory Myeloma in Updated NCCN Guidelines
3
Inside the OCEANIC-STROKE Trial and What Asundexian Means for the Future of Stroke Prevention
4
Glucose Monitoring: Timing Makes Every Reading Count
5